14010
Titanium(III) chloride solution
10-15% TiCl3 basis
Synonym(s):
Titanium trichloride
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Recommended Products
Quality Level
reaction suitability
core: titanium
reagent type: catalyst
concentration
10-15% (TiCl3)
12% in hydrochloric acid
impurities
5-10% free acid (as HCl)
SMILES string
Cl[Ti](Cl)Cl
InChI
1S/3ClH.Ti/h3*1H;/q;;;+3/p-3
InChI key
YONPGGFAJWQGJC-UHFFFAOYSA-K
Looking for similar products? Visit Product Comparison Guide
Application
Catalyst for hydrogen desorption and nitrogen-nitrogen bond cleavage
Reagent for photocatalyst synthesis
Precursor for preparation of nanostructures for nanoskeletons
Reagent for photocatalyst synthesis
Precursor for preparation of nanostructures for nanoskeletons
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - STOT SE 3
target_organs
Respiratory system
supp_hazards
Storage Class
8B - Non-combustible corrosive hazardous materials
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Chemosphere, 250, 126240-126240 (2020-03-03)
The unexpected incorporation of ionic Mn and Fe in the crystalline structure of titanate nanowires was accomplished when a contaminated a titanium source was used. The presence of Mn (8.1 mg L-1) and Fe (4.3 mg L-1) result in the production of a novel
Applied Physics Letters, 99 (2011)
Nanoscale research letters, 5(11), 1829-1835 (2010-12-03)
Highly crystalline TiO(2) nanostructures were prepared through a facile inorganic acid-assisted hydrothermal treatment of hexagonal-structured assemblies of nanocrystalline titiania templated by cetyltrimethylammonium bromide (Hex-ncTiO(2)/CTAB Nanoskeleton) as starting materials. All samples were characterized by X-ray diffraction (XRD) and transmission electron microscopy
Catalysis Today, 161, 169-174 (2011)
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 153, 105488-105488 (2020-07-28)
Atomoxetine (ATX), a selective and potent inhibitor of the presynaptic norepinephrine transporter, is used mainly to treat attention-deficit hyperactivity disorder. Although multiple adverse effects associated with ATX have been reported including severe liver injuries, the mechanisms of ATX-related toxicity remain
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service